The Serious Challenge of Occult Hepatitis B Virus Infection-Related Hepatocellular Carcinoma in China
ConclusionIt is estimated that at least 21 million OBI patients live in China. HBcAb(+) was not only the evidence of chronic HBV infection but also a dangerous mark for surface antigen-negative patients. A semi-annual or annual medical checkup is essential for all OBI patients to identify HCC as early as possible. The hypothesis underlying our analysis was that hepatitis B surface antibody would prevent the progress of HCC and facilitate the clearance of HBV in patients with OBI. Thereby, the hepatitis B vaccine could be used to prevent severe disease consequences.
Source: Frontiers in Microbiology - Category: Microbiology Source Type: research
More News: Biochemistry | Cancer & Oncology | Carcinoma | China Health | Chronic Pain | Epidemiology | Hepatitis | Hepatitis B | Hepatitis Vaccine | Hepatocellular Carcinoma | Liver Cancer | Microbiology | Pain | Vaccines | Virology | Women